X

Trial Profile

Effect of Inhaled Insulin (AERx iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes.

Status: Discontinued

Phase of Trial: Phase III

Latest Information Update: 07 Sep 2018

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Insulin (Primary) ; Pioglitazone
Indications Type 2 diabetes mellitus
Focus Therapeutic Use
Sponsors Novo Nordisk

Most Recent Events

13 Oct 2009 Actual initiation date changed from Dec 2006 to Nov 2006 as reported by ClinicalTrials.gov.
31 Jan 2008 Status change from in progress to discontinued, as reported by clinicaltrials.gov.
22 Jan 2008 The expected completion date for this trial is now 1 Jan 2008 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com